ADVERTISEMENT

Migraine in women: soy isoflavones show promise

Susan London   |   Clinical Summary   |   05 August 2022
ADVERTISEMENT

Takeaway

  • Women of reproductive age with migraine had greater reductions in attack frequency and duration and greater improvement in migraine-specific quality of life after 8 weeks of soy isoflavones vs placebo.

Why this matters

  • Conventional migraine pharmacotherapy has limited efficacy and associated adverse effects and cost.

Key results

  • In the...

          

November Challenge

Ends in 1d 16h
left
right

Topic Challenges

left
right